Lipase-catalyzed Transesterification of Medium-chain Triacylglycerols and a Fully Hydrogenated Soybean Oil

Although hydrogen is the most abundant element in the universe, it is not possible to find it in its purest state in nature. In this study, two-stage experimentation was carried out. The first stage was hydrogen production. The second stage was an electrochemical process to hydrogenate soybean oil in a PEM fuel cell. In the fist stage a Zirfon Perl UTP 500 membrane was used in an alkaline hydrolizer of separated gas to produce hydrogen, achieving 9.6 L/min compared with 5.1 L/min, the maximum obtained using a conventional membrane. The hydrogen obtained was used in the second stage to feed the fuel cell hydrogenating the soybean oil. Hydrogenated soybean oil showed a substantial diminished iodine index from 131 to 54.85, which represents a percentage of 58.13. This happens when applying a voltage of 90 mV for 240 min, constant temperature of 50 °C and one atm. This result was obtained by depositing 1 mg of Pt/cm 2 in the cathode of the fuel cell. This system represents a viable alternative for the use of hydrogen in energy generation.

Download Full-text

Administration of an Intravenous Fat Emulsion Enriched with Medium-Chain Triglyceride/ω-3 Fatty Acids is Beneficial Towards Anti-Inflammatory Related Fatty Acid Profile in Preterm Neonates: A Randomized, Double-Blind Clinical Trial

Nutrients ◽

10.3390/nu12113526 ◽

2020 ◽

Vol 12 (11) ◽

pp. 3526

Author(s):

Panos Papandreou ◽

Aristea Gioxari ◽

Dimitrios Ntountaniotis ◽

Olga-Natalia Korda ◽

Maria Skouroliakou ◽

...

Keyword(s):

Fatty Acid ◽

Linoleic Acid ◽

Soybean Oil ◽

Medium Chain Triglyceride ◽

Preterm Neonates ◽

Control Group ◽

Fat Emulsion ◽

Double Blind ◽

Intravenous Fat Emulsion ◽

Medium Chain

Intravenous administration of pure soybean oil emulsions high in linoleic acid may lead to inflammation and lipid peroxidation in preterm neonates. We aimed to investigate the effects of a medium-chain triglyceride (MCT)/ω-3 polyunsaturated fatty acid (PUFA)-enriched intravenous fat emulsion (IVFE) on plasma fatty acid (FA) profile and serum interleukin-6 (IL-6) in preterm neonates. In this double-blind randomized study, 92 preterm neonates (gestational age < 32 weeks, birth weight < 1500 g) were assigned to receive either MCT/ω-3 PUFA-enriched IVFE (Intervention Group) or soybean oil-based IVFE (Control Group). Levels of FAs were measured at baseline (day 0) and day 15 of parenteral nutrition with gas-chromatography mass-spectrometry. Serum IL-6 was measured with sandwich ELISA in 59 neonates. Plasma FAs changed significantly over time; the MCT/ω-3 PUFA-IVFE group showed higher ω-3 PUFAs (p = 0.031), eicosapentaenoic acid (p = 0.000), and oleic acid (p = 0.003), and lower ω-6/ω-3 PUFAs ratio (p = 0.001) and ω-6 PUFAs (p = 0.023) compared to control group. Linoleic acid was higher in the soybean oil (SO)-based IVFE arm compared to the MCT/ω-3 PUFAs-IVFE arm (p = 0.006). Both fat emulsion types decreased IL-6 compared to baseline, but changes were insignificant between groups. Administration of MCT/ω-3 PUFA-enriched IVFE in preterm neonates is beneficial in changing the FA profile consistent with attenuated inflammatory response.

Download Full-text